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Differential interactions of the formins INF2,
mDia1, and mDia2 with microtubules
Jeremie Gaillarda, Vinay Ramabhadranb, Emmanuelle Neumannec, Pinar Gurelb, Laurent Blanchoina,
Marylin Vantarda, and Henry N. Higgsb
a

CEA, iRTSV, Laboratoire Physiologie Cellulaire & Végétale, CNRS, UMR5168, Université Joseph Fourier-Grenoble I,
F-38054 Grenoble, France; bDepartment of Biochemistry, Dartmouth Medical School, Hanover, NH 03755; cInstitut
de Biologie Structurale Jean-Pierre Ebel, CNRS, CEA, University Joseph Fourier, F-38027 Grenoble, France

ABSTRACT A number of cellular processes use both microtubules and actin filaments, but
the molecular machinery linking these two cytoskeletal elements remains to be elucidated in
detail. Formins are actin-binding proteins that have multiple effects on actin dynamics, and
one formin, mDia2, has been shown to bind and stabilize microtubules through its formin
homology 2 (FH2) domain. Here we show that three formins, INF2, mDia1, and mDia2, display important differences in their interactions with microtubules and actin. Constructs containing FH1, FH2, and C-terminal domains of all three formins bind microtubules with high
affinity (Kd < 100 nM). However, only mDia2 binds microtubules at 1:1 stoichiometry, with
INF2 and mDia1 showing saturating binding at approximately 1:3 (formin dimer:tubulin dimer). INF2-FH1FH2C is a potent microtubule-bundling protein, an effect that results in a large
reduction in catastrophe rate. In contrast, neither mDia1 nor mDia2 is a potent microtubule
bundler. The C-termini of mDia2 and INF2 have different functions in microtubule interaction,
with mDia2’s C-terminus required for high-affinity binding and INF2’s C-terminus required for
bundling. mDia2’s C-terminus directly binds microtubules with submicromolar affinity. These
formins also differ in their abilities to bind actin and microtubules simultaneously. Microtubules strongly inhibit actin polymerization by mDia2, whereas they moderately inhibit mDia1
and have no effect on INF2. Conversely, actin monomers inhibit microtubule binding/bundling by INF2 but do not affect mDia1 or mDia2. These differences in interactions with microtubules and actin suggest differential function in cellular processes requiring both cytoskeletal elements.
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INTRODUCTION
Actin filaments and microtubules play coordinated roles in a wide
variety of cellular processes, including cell migration, membrane
transport, and cell division (reviewed in Goode et al., 2000;
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Rodriguez et al., 2003). In addition, there is evidence that these
two cytoskeletal elements interact physically in cytoplasm (Schliwa
and van Blerkom, 1981; Waterman-Storer et al., 2000; Schuh and
Ellenberg, 2008; Korobova and Svitkina, 2010). The proteins that
link actin and microtubules in specific processes are still largely a
matter of debate. A number of proteins could serve as intermediaries by binding both actin filaments and microtubules, including
formins (reviewed in Bartolini and Gundersen, 2010), adenomatous polyposis coli (APC; Okada et al., 2010), myosin 1C (Rump
et al., 2011), and doublecortin (Tsukada et al., 2005). Other proteins, such as WHAMM, WASH, and JMY, could serve as links by
binding Arp2/3 complex and microtubules (reviewed in Rottner
et al., 2010).
The large number of mammalian formin proteins (15 genes
and multiple splice variants; Higgs and Peterson, 2005) provides
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wide-ranging possibilities for coordinating actin and microtubules.
Formins bind actin mainly through their dimeric formin homology
2 (FH2) domain, which can both accelerate filament nucleation and
modulate elongation rate by remaining bound to the growing filament barbed end (reviewed in Higgs, 2005). The FH1 domain, adjacent to the FH2, is proline rich and binds the actin monomer-binding
protein profilin (reviewed in Paul and Pollard, 2009). Together, the
FH1-FH2 domains accelerate elongation, with the FH2 domain
bound to a filament barbed end and the profilin/actin–bound FH1
domain feeding actin monomers onto this barbed end. The C-terminal regions of some formins, including INF2 (Chhabra and Higgs,
2006), mDia1 (Gould et al., 2011), and FMNL3 (Vaillant et al., 2008;
E. G. Heimsath and H. N. Higgs, unpublished results), also have actin binding ability and contribute to actin dynamics.
Formins vary in their effects on actin. Whereas mDia1 appears
to be confined to accelerating nucleation and barbed-end elongation, other formins have additional effects by virtue of actin
filament side binding. Several formins bundle filaments, including Bnr1p, mDia2, Cappuccino, FMNL1, FMNL2, and FMNL3
(Moseley and Goode, 2005; Harris et al., 2006, 2010; Quinlan
et al., 2007; Vaillant et al., 2008). One formin, INF2, has the
unique property of accelerating both filament polymerization
and depolymerization, the depolymerization activity requiring an
actin monomer–binding DAD/WH2 motif C-terminal to the FH2
(Chhabra and Higgs, 2006).
The microtubule-binding properties of formins have been less
well characterized, but four mammalian formins (mDia2, INF1,
formin1, and formin2) and one Drosophila formin (Cappuccino)
have been shown to bind microtubules directly (Rosales-Nieves
et al., 2006; Zhou et al., 2006; Quinlan et al., 2007; Bartolini et al.,
2008; Young et al., 2008). Of these formins, three (mDia2, formin2,
and Cappuccino) require the FH2 domain for microtubule binding,
and two (INF1 and formin1) use sequences outside the FH2. INF1
possesses two C-terminal microtubule-binding motifs capable of
bundling microtubules in vitro and in cells (Young et al., 2008),
whereas regions in the N-terminus of formin2 appear to mediate
microtubule binding (Zhou et al., 2006). mDia2 constructs containing FH1, FH2, and C-terminal regions (FH1FH2C) stabilize microtubules against cold- and dilution-induced depolymerization (Bartolini
et al., 2008). Of interest, FH2 mutations that prevent actin association in mDia2 do not affect microtubule binding and stabilization
(Bartolini et al., 2008). Only one formin (Cappuccino) has been
shown to bind actin filaments and microtubules simultaneously
(Rosales-Nieves et al., 2006). Microtubule binding by both formin2
and Cappuccino is inhibited by the Spire KIND domain (Quinlan
et al., 2007).
In cells, several formins have clear effects on microtubules. Overexpression of FH2-containing constructs for mDia1 (Ishizaki et al.,
2001) or FHOD1 (Gasteier et al., 2005) causes alignment of actin
filaments and microtubules. Expression or activation of either mDia1
or mDia2 causes an increase in stable microtubules, and mDia1
knockdown decreases stable microtubules in multiple cell types (reviewed in Bartolini and Gundersen, 2010). In addition to their own
microtubule-binding ability, mDia1 and mDia2 can bind two other
microtubule-binding proteins, APC and EB1 (Wen et al., 2004). Another Dia formin, mDia3, is necessary for stable kinetochore–microtubule interaction (Yasuda et al., 2004; Cheng et al., 2011). Overexpression of INF1 C-terminus causes microtubule bundling and an
increase in microtubule acetylation (Young et al., 2008). Finally, there
are several examples of formin-mediated microtubule network reorganization. During T cell–APC interaction, both mDia1 and FMNL1
are necessary for MTOC reorientation in T cells toward the antigen4576 | J. Gaillard et al.

FIGURE 1: Schematic diagrams of mDia1, mDia2, and INF2 primary
structures. Domain boundaries are approximately to scale. For the
domains relevant to this work, the boundaries are as follows: mDia1
(mouse): 1255 residues total; FH1, 559–747; FH2, 752–1148; DAD,
1182–1192. mDia2 (mouse): 1171 residues total; FH1, 554–596; FH2,
615–1007; DAD, 1041–1051. INF2 (human, CAAX splice variant): 1249
residues total; FH1, 421–520; FH2, 554–940; DAD/WH2, 973–985.
The C-terminal regions of the proteins are indicated by brackets:
mDia1, 1149–1255; mDia2, 1009–1171; INF2, 941–1249. Boundaries
of the constructs used for these studies are given in Materials and
Methods.

presenting cell (Eisenmann et al., 2007; Gomez et al., 2007). During
meiosis in mammalian oocytes, the spindle migrates to the cell periphery, dependent upon an actin meshwork assembled by formin2
(Azoury et al., 2008; Li et al., 2008; Schuh and Ellenberg, 2008). During Drosophila oocyte development, mutations in Cappuccino
cause premature onset of microtubule-based cytoplasmic streaming
(Theurkauf, 1994; Dahlgaard et al., 2007).
To summarize, all formins tested are capable of binding microtubules, and formins can exert effects on microtubule stability and
positioning in cells. In this study, we compare three formins, INF2,
mDia1, and mDia2, to address fundamental features of microtubule
binding and the crossover effects between actin and microtubules.
We find that these formins display multiple differences in their interactions with microtubules, suggesting that formins differ in their
abilities to interact simultaneously with actin filaments and microtubules in cells.

RESULTS
We compared the microtubule-binding properties of three formins,
INF2, mDia1, and mDia2, focusing on the following aspects: microtubule-binding affinity and stoichiometry; microtubule-bundling activity; effects of microtubules on actin polymerization/depolymerization; and effect of actin on microtubule binding/bundling. The
constructs used for these studies consist of the FH1 domains, FH2
domains, and C-terminal regions of these proteins (Figure 1), since
these encompass the actin-binding regions and were used previously for microtubule-binding studies of mDia2 (Bartolini et al.,
2008).

Microtubule binding by INF2, mDia2, and mDia1 constructs
We used pelleting assays of Taxol-stabilized microtubules to determine binding affinity and stoichiometry for the FH1-FH2-C constructs of INF2, mDia1, and mDia2. All three formins bind microtubules with similar affinities of <100 nM (Figure 2A). However, there
are substantial differences in binding stoichiometries, with mDia2
binding at ∼1:1 (tubulin dimer:formin dimer) and INF2 and mDia1
binding at closer to 3:1 (Figure 2, A and E).
To test whether the C-terminal region contributes to microtubule-binding affinity or stoichiometry, we tested the FH1-FH2
Molecular Biology of the Cell

the fact that the C-termini are oriented in opposite directions in the GST dimer (McTigue
et al., 1995) bears some resemblance to the
antiparallel orientation of the C-termini in
the FH2 dimer (Xu et al. 2005). GST alone
displays no apparent binding to microtubules when tested at 20 μM (Figure 2D).
The C-terminus of mDia2 binds microtubules with measurable affinity (Kd = 0.71 μM;
Figure 2D). In addition, GST-mDia2-Cterm
binds microtubules with higher stoichiometry (0.6:1 tubulin dimer:GST dimer) than the
FH1FH2 or FH1FH2C constructs (Figure 2C).
In contrast, the C-termini of INF2 and mDia1
display very low affinity for microtubules,
with minimal binding at concentrations up
to 20 μM (Figure 2D). To summarize, the Cterminus of mDia2 contributes appreciably
to both microtubule-binding affinity and
stoichiometry, whereas the C-termini of
INF2 and mDia1 do not. Representative
SDS–PAGE gels from the binding assays are
shown in Supplemental Figure 1.

Microtubule bundling by formin
constructs
Because both INF1 and mDia2 have been
shown to bundle microtubules, we compared the bundling abilities of formin
FH1-FH2-C constructs. In fluorescence microscopy assays using Taxol-stabilized microtubules (Alexa 568 labeled), INF2-FH1FH2C
is a potent microtubule bundler. At a ratio of
4:1 tubulin:INF2 (dimer:dimer), the bundles
are much longer than individual microtubules
in the assay and incorporate INF2-FH1FH2C
(fluorescein labeled) evenly along their
length (Figure 3A), suggesting that INF2FH1FH2C causes organization of bundles
containing overlapping microtubules of
varying length. Bundling can be detected at
FIGURE 2: Microtubule binding by constructs of INF2, mDia1, and mDia2. Pelleting assays
ratios as high as 10:1 tubulin:INF2 (unpubusing 0.5 μM polymerized tubulin (dimer), Taxol stabilized. Formin concentrations represent
monomer concentration. (A) FH1FH2C constructs: INF2, mDia1, and mDia2. (B) INF2 constructs: lished data). In contrast, bundles are undetectable in assays containing equivalent
FH1FH2C and FH1FH2. (C) mDia2 constructs: FH1FH2C, FH1FH2, and GST-Cterm. (D) GST
fusions of C-termini of INF2, mDia1, and mDia2. Representative Coomassie-stained SDS–PAGE
amounts of INF2-FH1FH2 (Figure 3A). Simigels of some of the data are shown in Supplemental Figure S1. (E) Stoichiometries of formin
larly, mDia1-FH1FH2C does not cause nobinding to microtubules at saturation, determined by densitometry vs. a standard curve for each ticeable microtubule bundling by this assay
protein. Stoichiometries reflect the dimers of both tubulins and formins.
(Figure 3B). Small bundles of microtubules
are evident in the presence of mDia2-FHconstructs of INF2 and mDia2 in microtubule pelleting assays. INF21FH2C (Figure 3B), which is consistent with results for mDia2-FH1FH2
FH1FH2 binds microtubules with slightly lower affinity than the
(Bartolini et al., 2008). However, these bundles are not as extensive as
FH1-FH2-C construct (Kd of 250 vs. 90 nM) but with similar stoichithose created by INF2-FH1FH2C. We also conducted assays in a
ometry (2.6:1 vs. 3.4:1, tubulin dimer:formin dimer; Figure 2B). In
Taxol-free system that allows microtubule dynamics. Under these
contrast, the mDia2-FH1FH2 construct binds microtubules with conconditions, INF2-FH1FH2C also assembles extensive microtubule
siderably lower affinity (Kd of 1.8 μM vs. 65 nM) and lower stoichiombundles (Figure 3C).
etry (1.7:1 tubulin dimer:formin dimer; Figure 2C).
We examined the INF2-FH1FH2C–induced bundles in greater
To test microtubule binding by the C-termini directly, we used
detail using negative-stained electron microscopy. At a ratio of 1:1
glutathione S-transferase (GST)–fusion proteins of INF2, mDia1, and
(dimer:dimer), INF2-FH1FH2C causes assembly of thick bundles,
mDia2 constructs in microtubule pelleting assays. We consider the
often with widths of 100–125 nm (Figure 4). The majority of the bundimeric GST-fusion constructs to be more representative than
dles contain a large number of microtubules, and the overlapping
the cleaved C-terminal constructs in these assays, since the C-terminature of the microtubules complicates assessment of their detailed
nus is normally adjacent to the dimeric FH2 domain. Furthermore,
structure. Nevertheless, in the occasional bundles containing only a
Volume 22 December 1, 2011
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readily than single microtubules (Gaillard
et al., 2008). INF2-FH1FH2C causes a significant shift of tubulin to the pellet fraction,
whereas the INF2-FH1FH2 construct does
not (Supplemental Figure 3A). For mDia2FH1FH2C, there is a slight shift of tubulin to
the pellet at higher concentrations, whereas
mDia1-FH1FH2C does not have this effect
(Supplemental Figure 3B). We note that
bundling by INF2-FH1FH2C or mDia2-FH1FH2C is not due to aggregation of
the formins prior to mixing with microtubules, since both formins have been shown
to be dimeric by analytical ultracentrifugation (Li and Higgs, 2005; Chhabra and
Higgs, 2006) and since the proteins are centrifuged at 100,000 × g for 15 min in binding
buffer immediately prior to mixing with
microtubules.
To examine the dynamics of INF2-mediated microtubule bundles, we used total
internal reflection fluorescence (TIRF) microscopy of Alexa 568–labeled tubulin (red)
in the presence of green fluorescent protein
(GFP)–tagged INF2-FH1FH2C (green). In
these experiments, we incubated GMPCPPstabilized microtubules alone or preincubated with INF2 in order to obtain stable
microtubule seeds that were further elongated by the addition of Alexa 568–tubulin
with or without GFP-INF2 (Figure 5, A–C,
and Supplemental Movies S1 and S2), as
described for other microtubule-bundling
proteins (Fache et al., 2010). Microtubules
elongate from both ends of the bundles,
suggesting that individual microtubules in
the bundle are in an antiparallel or random
orientation (Supplemental Movie S1). Analysis of individual microtubule dynamics in
these bundles is challenging due to the
presence of multiple microtubules in close
proximity. In particular, there is uncertainty
as to whether the dynamics observed repFIGURE 3: Fluorescence micrographs of microtubule bundling by INF2-FH1FH2C.
(A) Fluorescence microscopy of Taxol-stabilized, Alexa 568–labeled microtubules (0.5 μM tubulin) resents individual microtubules or two or
in the absence or presence of fluorescein-labeled INF2-FH1FH2C or INF2-FH1FH2. Assays
more microtubules displaying similar dyconducted in actin polymerization buffer. Arrows point to INF2-FH1FH2 labeling individual
namics. Nevertheless, we observe a nummicrotubules. (B) Fluorescence microscopy of Taxol-stabilized, Alexa 568–labeled microtubules
ber of interesting features. First, the frein the absence or presence of 500 nM mDia1 or mDia2-FH1FH2C. Assays conducted in actin
quency of clear catastrophe events is
polymerization buffer. (C) Fluorescence micrographs of Alexa 568–tubulin (25 μM) polymerized
considerably decreased in bundles comin microtubule polymerization buffer for 45 min in the presence of the indicated additives.
pared with individual microtubules. From
Formin monomer concentrations are given in all cases. Scale bars, 20 μm.
analysis of 11 bundles for an average of
15 min per bundle, we identified only two
few microtubules, the intermicrotubule distance is 10–12 nm (Supclear catastrophe events (Figure 5C, stars) compared with the freplemental Figure 2A). This distance is significantly smaller than those
quent catastrophes that occur in individual microtubules (Figure
we previously measured for two other bundling proteins: 30 nm for
5A, kymograph, stars). Second, there are occasional pauses in
MAP65-1 (Gaillard et al., 2008) and 15 nm for MAP65-4 (Fache et al.,
growth of the bundles (Figure 5C, blue lines). Between these
2010). In contrast to INF2-FH1FH2C, no clear microtubule bundles
pauses, there are sustained periods of growth of one or more miare detected in the presence of INF2-FH1FH2 (Figure 4), mDia1crotubules in the bundle (Figure 5C, arrows), and the elongation
FH1FH2C, or mDia2-FH1FH2C (Supplemental Figure 2B) using
rate in these periods is 1.5 μm/min (Figure 5D, n = 48), similar to
electron microscopy.
the rate of microtubules that are not in bundles (1.7 μm/min
These microtubule-bundling results are supported by low-speed
(Figure 5A; Fache et al., 2010). Third, the overall elongation rate of
centrifugation assays, in which microtubule bundles sediment more
the bundles is slower (0.89 μm/min [n = 11]; Figure 5D) than the
4578 | J. Gaillard et al.
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A concentration of microtubules (1.5 μM) sufficient to bind >95%
of INF2-FH1FH2C has no apparent effect on its ability to accelerate
actin polymerization (Figure 6A). In contrast, microtubules have a
potent inhibitory effect on mDia2 in these assays, with concentrations as low as 30 nM suppressing actin polymerization significantly
(Figure 6B). In addition, mDia2’s C-terminus is required for inhibition
by microtubules, since actin polymerization by mDia2-FH1FH2 is
not inhibited at any concentration tested (Figure 6D). Microtubules
partially inhibit actin polymerization by mDia1 (Figure 6C). This partial inhibition has an IC50 of ∼1 μM and clearly reaches a plateau
(compare the 2 and 3 μM curves in Figure 6C), indicating that the
partial effect is not due to subsaturating microtubule concentrations. Because these formins influence barbed-end elongation to
different extents (Kovar et al., 2006; Chhabra and Higgs, 2006), we
quantified the inhibitory effect by determining the time required to
reach polymerization of half of the actin monomers (T1/2). By this
analysis, microtubules have an IC50 of 47 nM for mDia2 (Figure 6D),
which is similar to mDia2’s Kd for microtubule binding. In contrast,
microtubules inhibit mDia1 with an IC50 of 940 nM, significantly
higher than mDia1’s Kd for microtubule binding.
INF2 possesses the ability to accelerate both actin polymerization and depolymerization. For this reason, we tested the effect of
microtubules on actin depolymerization by INF2-FH1FH2C, using a
pyrene–actin depolymerization assay (Chhabra and Higgs, 2006).
Microtubules do not inhibit actin depolymerization by INF2FH1FH2C (Figure 6E). Of importance, none of these results (actin
polymerization or depolymerization by INF2-FH1FH2C or actin polymerization by mDia1- or mDia2-FH1FH2C) is altered by the presence of 3 μM profilin (unpublished data).

Effects of actin on microtubule binding by INF2, mDia1,
and mDia2

FIGURE 4: Negative-stained electron microscopy of microtubule
bundles assembled by INF2-FH1FH2C. Taxol-stabilized microtubules
(2 μM tubulin dimer) were incubated in the absence (E) or in the
presence of 4 μM INF2-FH1FH2 (A, B) or 4 μM INF2-FH1FH2C
(C, D, F). INF2 monomer concentrations are given. (F) Highmagnification view of the MT bundle shown in D.

elongation rate of microtubules, suggesting that pauses must be
more frequent than we observe, due to the complexity of the
kymographs. Of interest, INF2 binding to growing microtubule
bundles is rapid, as we observe no apparent region in which the
red label precedes green on the elongating filament in the timelapse acquisition of the experiment (one frame every 5 s; Figure 5B
and Supplemental Movie S2).

Effects of microtubules on actin dynamics by INF2, mDia1,
and mDia2
Because these formins can interact with both actin and microtubules, we asked whether the binding of one cytoskeletal component could affect binding of the other. We used pyrene–actin polymerization assays to test the effect of microtubules on the abilities of
FH1FH2C constructs to accelerate actin polymerization. Before describing the results, we note that other buffer components introduced with the microtubules (Taxol, GTP, 1,4-piperazinediethanesulfonic acid [PIPES] buffer) are kept constant in the assays and do not
affect the activities of the INF2, mDia1, and mDia2 constructs
tested.
Volume 22 December 1, 2011

We also tested the effects of actin on microtubule binding by these
formins. We used LatB-bound actin as an actin monomer pool and
phalloidin-stabilized actin as an actin filament pool. In the absence
of phalloidin, INF2-FH1FH2C accelerates filament depolymerization
(Chhabra and Higgs, 2006), and so phalloidin is necessary to prevent accumulation of actin monomers during the experiment.
Initially, we used fluorescence microscopy assays to test the effect of actin monomers and filaments on microtubule bundling by
INF2-FH1FH2C. Actin monomers strongly inhibit microtubule bundling by INF2-FH1FH2C (compare Figure 7, A and B). The presence
of profilin eliminates this effect of actin monomers (Figure 7C). In
contrast, actin filaments have no apparent effect on microtubule
bundling by INF2-FH1FH2C (Figure 7D). We quantified these effects by counting the number of individual microtubules present in
the micrographs from each condition tested. This quantification reveals that only the actin monomer treatment, and not actin filaments,
results in a large increase in individual microtubules (Table 1).
INF2-FH1FH2C can bind actin filaments in two ways: it binds filament barbed ends and it binds filament sides, leading to filament
severing (Chhabra and Higgs, 2006). For this reason, we conducted
additional tests to favor barbed-end or side-bound INF2. To favor
barbed ends, we sheared actin filaments through a 27-gauge needle immediately prior to mixing with INF2-FH1FH2C. This procedure increases barbed end concentration dramatically (Harris et al.,
2006). To limit the number of barbed ends, we included 10 mM
potassium phosphate in the assay, which inhibits severing by INF2FH1FH2C (Chhabra and Higgs, 2006). The presence of actin filaments does not inhibit microtubule bundling under either condition
(Table 1). Our conclusion is that actin monomers, but not actin filaments, inhibit the ability of INF2-FH1FH2C to bundle microtubules.
Formins and microtubules
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FIGURE 5: Microtubule dynamics in bundles induced by INF2-FH1FH2C. (A) Dynamic instability behavior of individual
microtubules. The microtubule seeds (0.5 μM) are in red (Alexa 568–labeled tubulin), and elongating microtubule
segments are in green (Alexa 488–labeled tubulin, 22 μM). (a–e) Growth and shortening at both microtubule ends
observed in dual-view images from a time-lapse series (see Supplemental Movie S1). Time is in seconds; scale bar, 5 μm.
The associated kymograph shows the microtubule elongation (red arrows) and catastrophe events (stars) of the
microtubule at the center of the image. The microtubule seed is indicated by dotted lines. (B) Dual-view image series of
the assembly of a microtubule bundle (see Supplemental Movie S2). Microtubule seed bundles were grown by adding
Alexa 568–labeled tubulin (22 μM) in the presence of GFP-INF2 (0.5 μM monomer). Time is in seconds; bar, 5 μm. The
corresponding kymograph indicates that the density of microtubules is high. Microtubules do not exhibit noticeable
catastrophe and pause events, and microtubules grow progressively for nearly 15 min in this example. (C) Additional
kymographs of microtubule bundles, showing examples of growth (red arrows), pauses (blue lines), and the only two
catastrophe events observed in analyzing 11 bundles over an average of 15 min (stars). Scale bar, as in B. (D) Analysis of
microtubule and bundle elongation in presence of INF2. (Left) Histogram of the mean elongation rates of microtubules
during growth phases, when bundled by INF2 (n = 48). The average elongation rate is 1.54 μm/min. SD = 0.26,
SE = 0.037. (Right) Histogram of the elongation rate of MT bundles (n = 11). The average elongation rate is 0.89 μm/min.
SD = 0.22, SE = 0.066.

Next we used high-speed pelleting assays to examine the effect
of actin on microtubule binding by INF2, mDia1, and mDia2. Because
actin filaments pellet under these conditions, we could not examine
the effects of filaments on microtubule binding and examined only
4580 | J. Gaillard et al.

the effect of actin monomers in these assays. The presence of actin
monomers strongly inhibits microtubule binding by INF2-FH1FH2C
(Figure 7E), with an IC50 of 0.54 μM (Figure 7F and Supplemental
Figure S4A). This effect is overcome by profilin (Figure 7E).
Molecular Biology of the Cell

FIGURE 6: Microtubules inhibit actin polymerization by mDia1 and mDia2 but not by INF2. (A–C) Pyrene–actin
polymerization assays using 1 μM actin (10% pyrene labeled) and 10 nM INF2-FH1FH2C (A), 5 nM mDia2-FH1FH2C (B),
or 5 nM mDia1-FH1FH2C (C). Blue labels indicate nanomolar concentrations of MTs added in addition to the formin and
actin. Inset in B shows expanded time course of polymerization (to 3600 s). (D) concentration curves of MT effects on
the three formins (as well as mDia2-FH1FH2), plotted as T1/2 (time required to reach one-half of maximal actin
polymerization). T1/2 for actin alone is 3122 s ± 152 (n = 8). (E) Pyrene–actin depolymerization assays in which 1.1 μM
actin (10% pyrene labeled) is diluted to 1 μM in the presence or absence of INF2-FH1FH2C (250 nM) and/or
microtubules (MTs, 750 nM). Formin monomer concentrations are given.

While testing the other formins in these pelleting assays, we
experienced an interesting phenomenon, which confounded analysis somewhat. Each of these formin constructs (INF2-FH1FH2,
mDia1-FH1FH2C, and mDia2-FH1FH2C) pellet to a small degree
with actin monomers (Figure 7E and Supplemental Figure S4,
B and C). In each case, the stoichiometry of pelleting is ∼4:1 actin
monomer:formin dimer, with 10% of the actin (0.25 μM) and 25%
of the formin (0.125 μM formin monomer) in the pellet. This effect
is inhibited by profilin for mDia2 (Figure 7E) and INF2-FH1FH2
(Supplemental Figure S4B) but not as much for mDia1 (Supplemental Figure S4C). INF2-FH1FH2C does not pellet with actin
monomers in this manner.
Despite this actin monomer effect on these formins, we can still
draw conclusions on their effects on microtubule binding. Similar to
the INF2-FH1FH2C construct, INF2-FH1FH2 binding to microtubules is inhibited by actin monomers in a profilin-sensitive manner
(Supplemental Figure S4B). In contrast, neither mDia1 nor mDia2
pelleting with microtubules is inhibited by actin monomers, either in
the presence or absence of profilin (Figure 7E and Supplemental
Figure S4C). In fact, actin monomer binding by the mDia2 construct
actually appears to be inhibited by microtubules, since less actin
monomer accumulates in the pellet when microtubules are
present.
Using fluorescence microscopy, we tested directly whether these
formins could interact simultaneously with phalloidin-stabilized actin
filaments (labeled with Alexa 568–phalloidin) and Taxol-stabilized
microtubules (labeled with Alexa 488). The actin filaments are prepolymerized in the presence of equimolar phalloidin, so that the
concentration of actin monomers is extremely low in these assays
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and thus not likely to inhibit INF2 binding to microtubules. Mixed
populations of actin filaments and microtubules do not form apparent coaggregates. In the presence of INF2-FH1FH2C, coaggregates
of actin and microtubules appear, despite the fact that most of the
nonaggregated actin filaments are extremely short due to INF2mediated severing (Figure 8). INF2 does not bundle actin filaments
alone (Chhabra and Higgs, 2006), suggesting that these coaggregates of actin and microtubules are due to actin filament binding by
INF2 that is bound to microtubules. We cannot determine in these
experiments whether the actin filaments in these aggregates are
small fragments or longer filaments, but we suspect that they are
INF2-severed small fragments and that INF2 is bound to their
barbed ends.
mDia1-FH1FH2C does not cause extensive coaggregation
(Figure 8), which is not surprising because it bundles neither actin
filaments (Harris et al., 2006) nor microtubules (this study). mDia2FH1FH2C causes formation of actin filament bundles, as shown previously (Harris et al., 2006). However, these bundles do not appear
to associate with microtubules (Figure 8). Thus, although microtubules potently inhibit the ability of mDia2 to stimulate actin polymerization, mDia2 is still able to bundle actin filaments in the presence of microtubules.

DISCUSSION
In this study, we show that FH1FH2C constructs of INF2, mDia1, and
mDia2 have distinct microtubule interaction properties (Table 2). All
three formins bind microtubules with high affinity. However, the
binding stoichiometries are very different, with INF2 and mDia1 dimers at ∼1:3 and mDia2 dimer at close to 1:1 with tubulin dimers.
Formins and microtubules
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FIGURE 7: Actin monomers inhibit INF2-FH1FH2C binding to microtubules. (A–D) Fluorescence microscopy of
Taxol-stabilized, Alexa 568–labeled microtubules (MT; 0.5 μM tubulin dimer) and 0.2 μM INF2-FH1FH2C alone (A), with
2 μM LatB-stabilized actin monomers (B; threefold molar excess of LatB), 2 μM profilin-bound actin monomers
(C; threefold molar excess of profilin), or 2 μM phalloidin-stabilized actin filaments (D; 1.5-fold molar excess of
phalloidin). Scale bar, 20 μm. Quantification of bundling is given in Table 1. (E) High-speed pelleting assays containing
Taxol-stabilized microtubules (MT; 0.5 μM tubulin dimer) in the absence or presence of 0.5 μM FH1FH2C construct (INF2
or mDia2), 2.5 μM LatB-stabilized actin monomers (LBA; twofold molar excess of LatB), and 2.5 μM LatB-stabilized actin
monomers with 7.5 μM profilin (LBAP). Assays are conducted in actin polymerization buffer. Pellet fractions are shown
here. Formin monomer concentrations are given. (F) Concentration curve showing actin monomer inhibition of
INF2-FH1FH2C binding to microtubules. INF2-FH1FH2C (monomer) and tubulin (dimer) concentrations are fixed at
0.5 μM. The y-axis reflects percentage of INF2-FH1FH2C bound, with 100% being the value without actin monomers
present.

INF2 is a potent microtubule bundler, whereas mDia2 is a much
weaker bundler and mDia1 displays no apparent microtubule bundling. Microtubules do not inhibit actin interactions by INF2, but
actin monomers inhibit its microtubule–binding/bundling activities.

Condition
MT alone
MT + INF2
MT + INF2 + actin monomers
MT + INF2 + actin monomers + profilin

Number of individual
microtubules
516
1
424
9

MT + INF2 + actin filaments

24

MT + INF2 + actin filaments (sheared)

13

MT + INF2 + actin filaments + PO4

34

The number of individual microtubules present under the indicated condition was counted from fluorescence micrographs (total area counted was
143,000 μm2 for each condition), with a larger number of free microtubules
signifying lower bundling efficiency. Experimental conditions: Taxol-stabilized,
Alexa 568–labeled microtubules (MT, 0.5 μM tubulin dimer), 0.2 μM INF2FH1FH2C, 2 μM LatB-stabilized actin monomers (threefold molar excess of
LatB), 2 μM profilin-bound actin monomers (threefold molar excess of profilin
to LatB/actin), 2 μM phalloidin-stabilized actin filaments, 1.5-fold molar excess
of phalloidin), 10 mM NaPO4, pH 7.0. Shearing of actin filaments through a
27-gauge needle prior to mixing with INF2.

TABLE 1: Effect of actin monomers and actin filaments on
microtubule bundling by INF2-FH1FH2C.
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In contrast, mDia1 and mDia2 bind microtubules in the presence of
actin monomers, but their actin polymerization activities are inhibited by microtubules. mDia2 is the most dramatic in this respect,
with nanomolar microtubule concentrations causing complete inhibition of actin polymerization. INF2 causes coaggregation of microtubules with actin, whereas such coaggregation is not detectable
with mDia1 or mDia2.

Differences in microtubule binding among formins
One conclusion from this study, taken with previously published
work, is the following: although all formins tested can bind microtubules, the mechanisms of binding vary. An illustration of this statement is the differential contribution of the C-terminus to microtubule interactions. For INF2, the C-terminus does not contribute
significant binding affinity but is necessary for microtubule bundling.
For mDia2, the C-terminus is necessary for high-affinity microtubule
binding, as well as to obtain 1:1 stoichiometry, since mDia2’s
FH1FH2 binds microtubules substoichiometrically and with only
moderate affinity, in agreement with previous work (Bartolini et al.,
2008). In fact, the mDia2 C-terminus alone binds microtubules with
significant affinity (Kd = 0.7 μM), whereas the C-termini of INF2 and
mDia1 display negligible affinity.
What features of mDia2’s C-terminus allow it to bind microtubules? We can narrow the important residues in this 164–amino
acid region by the fact that mDia1 and mDia2 are highly homologous through the DAD, with the subsequent 109 residues of mDia2
significantly diverging from the remaining 54 residues of mDia1
(Supplemental Figure S5). Because mDia1-Cterm does not bind
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INF2

mDia2

mDia1

MT binding Kd FH1FH2C

90 nM

65 nM

60 nM

MT binding stoichiometry FH1FH2Ca

3.4:1

0.91:1

3.09:1

MT binding Kd FH1FH2

250 nM

1800 nM

nd

MT binding stoichiometry FH1FH2

2.7:1

1.7:1

nd

MT binding Kd Cterm

>20 μM

0.71 mM

>20 μM

MT binding stoichiometry Cterm

—

0.6:1

—

MT bundling

Yes

Weak

No

Actin monomer effect on MT binding

Inhibits

No effect

No effect

MT effect on actin polymerization

No effect

Strong inhibition

Weak inhibition

Coaggregation of microtubules and actin

Yes

No

No

a

a

b

MT stabilization

Stabilizes

Stabilizes

nd

Role of C-terminus

Required for bundling

Required for high-affinity/
stoichiometry binding

nd

—, too weak to measure Kd; nd, not determined.
a
Ratio of tubulin dimer:formin dimer.
b
From Bartolini et al. (2008).

TABLE 2: Properties of microtubule binding for INF2, mDia1, and mDia2.

microtubules tightly, we postulate that mDia2 binds microtubules
through residues C-terminal to DAD. This region is highly basic (a pI
of 10.23), which is favorable for electrostatic interactions with the
acidic microtubule surface. Three basic motifs capable of binding
microtubules are the K loop of the kinesin Kif1a (Okada and Hirokawa, 1999), the neck domain of the kinesin MCAK (Ovechkina
et al., 2002), and the MTB1 sequence at the C-terminus of INF1
(Young et al., 2008). mDia2’s C-terminus does not possess the salient features of these sequences (nor those of MTB2 of INF1) and
thus might represent a distinct microtubule-binding motif. We do

not know whether this region folds into a stable structural domain
or is induced to fold upon interaction with microtubules.
The fact that mDia2-FH1FH2C binds microtubules with different
stoichiometry from INF2 or mDia1 is also intriguing and appears to
be a contribution of the C-terminus. We present two possible explanations for the stoichiometry differences. The first is that binding of
one molecule of INF2 or mDia1 to the microtubule sterically occludes binding of neighboring molecules, resulting in a maximal occupancy of only one-third of the tubulin dimers. The microtubulebinding protein, Tau, also binds substoichiometrically to tubulin

FIGURE 8: INF2 assembles coaggregates of microtubules and actin filaments. Fluorescence micrographs of Alexa
488–labeled microtubules (0.5 μM, Taxol stabilized, green) mixed with Alexa 568/phalloidin–stabilized actin filaments
(1 μM, red) in the presence of 0.5 μM of the indicated FH1FH2C construct (monomer concentration) for 30 min at 23°C
before imaging. Scale bar, 10 μm.
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dimers, with a 1:2 ratio (Gustke et al., 1994; Al-Bassam et al., 2002).
The second possibility is that both INF2 and mDia1 have strong
preferences for microtubules containing a specific number of protofilaments. This situation occurs for doublecortin, which prefers
binding to microtubules containing 13 protofilaments (Moores
et al., 2004). Even though 13 protofilaments is the predominant
configuration in cells, it is a minority population for microtubules
polymerized in vitro (Wade et al., 1990; Moores et al., 2004).
We do not rule out the possibility that mDia2 might dissociate
into monomers in order to bind microtubules, since the mDia2 FH2
dimer has a measurable off-rate, whereas the mDia1 FH2 dimer is
extremely stable (Harris et al., 2006). Perhaps supporting this hypothesis, a mutation that disrupts dimerization of mDia2’s FH2 still
allows microtubule stabilization in cells (Bartolini et al., 2008). The
stability of INF2’s FH2 dimer is unknown.
The potent microtubule-bundling activity of INF2 poses additional questions. Why is the C-terminus required for bundling, when
the FH1-FH2 domain construct binds microtubules with reasonable
affinity? We show that INF2’s C-terminus alone does not bind microtubules strongly, making it very different from INF1 in this regard.
One possibility is that INF2 C-terminus displays an alternate folding
pattern when attached to the FH1FH2, creating a new microtubulebinding site. Another microtubule-binding protein, PRC1, is differently folded when it bridges two adjacent microtubules as opposed
to when it is along the MT lattice without bundling (Subramanian
et al., 2010). We predict that INF2 C-terminus alone does not adopt
a stably folded structure (Chhabra and Higgs, 2006). As a separate
point, the fact that INF2 requires its C-terminus for bundling suggests that the FH2 can only interact with one microtubule, despite
being a dimer.

Differences in actin/microtubule effects among formins
It is perhaps not surprising that formins differ in microtubule-binding
mechanisms, since they differ considerably in their interactions with
actin. In some respects, mDia1 is the simplest in its actin interactions, being a potent nucleator and elongation factor, but with low
filament side–binding affinity and no apparent bundling activity (Li
and Higgs, 2003; Harris et al., 2004, 2006). In contrast, mDia2 is an
actin-bundling protein, in addition to its nucleation and elongation
activities (Harris et al., 2006). INF2 accelerates both actin polymerization and depolymerization, the latter dependent on filament severing (Chhabra and Higgs, 2006).
The effects of microtubules on actin binding, and vice versa,
vary considerably among these formins. mDia2’s ability to accelerate actin polymerization is strongly inhibited by microtubules.
However, mDia2 still bundles actin in the presence of microtubules, supporting previous results and suggesting that mDia2’s
nucleation and bundling activities are distinct (Harris et al., 2006).
For INF2, microtubules have no apparent effect on actin polymerization or depolymerization, whereas actin monomers inhibit microtubule binding and bundling. Nevertheless, INF2 can bind microtubules and actin filaments simultaneously. The partial inhibition
by microtubules of mDia1’s actin polymerization activity is curious,
since microtubules bind mDia1 and mDia2 with similar affinity.
These results further suggest fundamental differences in microtubule-binding mechanism, as well as the role of the C-terminus in
both actin (Chhabra and Higgs, 2006; Gould et al., 2011) and microtubule interactions.
It is not clear how these biochemical differences affect cellular
function, but we make three points. First, actin monomer concentration is >100 μM in the cytoplasm of many mammalian cells
(Pollard et al., 2000), which would inhibit strongly INF2–microtubule
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interaction. However, high concentrations of profilin in most cells
limit free actin monomer to <1 μM (Pollard et al., 2000). The effect
of actin monomers could depend on the activation state of the cell,
since actin monomer concentration is strongly reduced upon activation (Sotiropoulos et al., 1999). Second, the ability of microtubules to inhibit actin nucleation by mDia2 would depend on microtubule colocalization with active mDia2, raising potentially
interesting regulatory possibilities during cytokinesis (Watanabe
et al., 2008, 2010) and cell motility (Gupton et al., 2007). Third,
formins might have differential abilities to bind microtubules simultaneously with other MAPs. Doublecortin binds at the interface of
four tubulin dimers, a configuration that allows simultaneous kinesin binding (Fourniol et al., 2010). Conversely, MAP2c and Tau bind
along the protofilament ridge, and MAP2c at least partially occludes kinesin binding (Al-Bassam et al., 2002, 2007). Myosin 1C
binding to microtubules also inhibits kinesin motility (Rump et al.,
2011).
Our results provide fundamental information on microtubule
binding but clearly are not complete pictures of formin–microtubule
interactions. First, full-length formins might differ in important respects, including the following: 1) The autoinhibitory DID/DAD interaction could have important regulatory effects on microtubule
binding, as it does for actin binding (Li and Higgs, 2003) and as
Spire KIND does for Cappuccino/formin2 (Quinlan et al., 2007);
2) the dimerization domain between the DID and the FH1 domains
(Li and Higgs, 2005) might alter microtubule-binding dynamics; and
3) additional microtubule-binding sites might exist. Second, both
mDia1 and mDia2 can interact with the microtubule-binding proteins EB1 and APC, requiring the FH2 domain (Wen et al., 2004).
Whether these interactions would enhance or inhibit the formin’s
affinity for microtubules is unclear, but they provide interesting possibilities for cellular function.

MATERIALS AND METHODS
Protein preparation
All formin constructs were expressed in bacteria as GST-fusion proteins, following procedures used previously (Li and Higgs, 2003,
2005; Chhabra and Higgs, 2006; Harris et al., 2006). The constructs
used were mDia1-FH1FH2C (mouse, amino acids 548–1255),
mDia1-Cterm (1149–1255), mDia2-FH1FH2C (mouse, 521–1171),
mDia2-FH1FH2 (mouse, 521–1040), mDia2-Cterm (1009–1171),
INF2-FH1FH2C (human CAAX variant, 469–1249), INF2-FH1FH2
(human, 469–941), and INF2-Cterm (human CAAX variant, 941–
1249). After expression, extracts were passed over glutathione–Sepharose (GE Healthcare Bio-Sciences, Piscataway, NJ), cleaved with
either thrombin (mDia1, mDia2, and INF2-Cterm constructs) or tobacco etch virus protease (INF2-FH1FH2C and INF2-FH1FH2) to
elute the formin construct from GST, and further purified by ion exchange chromatography on SP Sepharose (mDia1), SourceS Sepharose (mDia2 constructs), or SourceQ Sepharose (INF2 constructs).
GST fusions of C-terminal constructs were eluted from glutathione–
Sepharose using glutathione and then gel filtered on Superdex
200 in K50MEID (50 mM KCl, 1 mM MgCl2, 1 mM ethylene glycol
tetraacetic acid [EGTA], 10 mM imidazole, pH 7.0, 1 mM dithiothreitol [DTT]). All chromatographic resins were from GE Biosciences.
Final buffer for formins was K50MEID.
Tubulin was prepared by polymerization–depolymerization cycling from freshly killed porcine brain. Then MAP-free tubulin was
purified by two techniques, giving similar results. In France, tubulin
was purified by cation exchange chromatography (EMD SO, 650 M;
Merck, Darmstadt, Germany) as described (Vantard et al., 1994) and
then polymerization–depolymerization cycled once more and stored
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as soluble dimer tubulin (concentration, ∼110 μM) in BRB buffer
(80 mM K-PIPES, pH 6.8, 1 mM EGTA, 1 mM DTT, and 1 mM MgCl2)
plus 1 mM GTP in liquid nitrogen. In the United States, tubulin was
purified by anion exchange chromatography on DEAE (macro-prep
DEAE; Bio-Rad, Hercules, CA) and gel filtration on Superdex 200,
adapting previously described procedures (Shelanski et al., 1973;
Borisy et al., 1974; Sloboda et al., 1976; Omoto and Johnson, 1986).
The Superdex 200 fraction was polymerization–depolymerization
cycled once more and stored in the polymerized form (concentration, ∼80 μM tubulin dimer) at −80°C after freezing in liquid nitrogen. The final buffer conditions were BRB plus 0.5 mM GTP.
Rabbit skeletal muscle actin was purified from acetone powder
(Spudich and Watt, 1971) and labeled with pyrenyliodoacetamide
(Cooper et al., 1983). Both unlabeled and labeled actin were gel
filtered on Superdex 200 (MacLean-Fletcher and Pollard, 1980) and
stored in G buffer (2 mM Tris-HCl, pH 8.0, 0.5 mM DTT, 0.2 mM ATP,
0.1 mM CaCl2, 0.01% sodium azide) at 4°C. Profilin (human profilin
I) was expressed in bacteria and purified following published procedures (Kovar et al., 2006).

Tubulin polymerization
An aliquot of frozen tubulin was removed from the −80°C freezer or
from liquid nitrogen, allowed to thaw on ice, and incubated for
10 min on ice after thawing. This fraction was centrifuged at 4°C
and 16,000 × g for 30 min in a microfuge. The protein concentration
of the supernatant fraction was determined by Bradford assay
(Bio-Rad), and then the fraction was diluted to 15 μM in BRB plus
2 mM GTP. This sample was incubated at 37°C for 5 min, followed
by addition of the following amounts of paclitaxel (Calbiochem, La
Jolla, CA) at 10-min intervals from 100-fold concentrated DMSO
stocks: 0.1, 1, and 20 μM. Polymerized tubulin was kept at 23°C
until used, not more than 4 h. Final conditions were 15 μM tubulin
and 21.1 μM paclitaxel in BRB plus 2 mM GTP.

Pelleting assays for microtubule binding and bundling
Microtubules (0.5 μM) and formin protein were mixed in microtubule-binding buffer (MTB; K50MEID + 0.1 mM GTP, 20 μM paclitaxel, and 0.5 mM thesit [nonaethylene glycol monodecyl ether,
P-9641; Sigma-Aldrich, St. Louis, MO]) at 25°C for 30 min and then
centrifuged at 100,000 × g in a TLA100 rotor (60,000 rpm; Beckman,
Coulter, Brea, CA) at 25°C for 15 min. Aliquots of supernatants were
removed, and pellets were washed briefly with KMEID and resuspended in SDS–PAGE sample buffer. Proteins were resolved by
SDS–PAGE, either on small (6-cm-tall Bio-Rad minigels) or large
(15-cm-tall Hoeffer [Holliston, MA] gels) gels of varying density (5.75,
10, or 15% acrylamide [Bio-Rad 37.5:1 acrylamide:bis-acrylamide]),
depending on the resolution required in the experiment. The α- and
β-tubulin bands are resolved on the 5.75% large-format gels, resulting in a doublet, whereas they migrate as a single band on 10 or
15% gels. Gels were stained with colloidal Coomassie (Invitrogen,
Carlsbad, CA) or subjected to Western blot analysis using anti-INF2
antibodies (Chhabra et al., 2009). Protein in pellet was quantified by
densitometry of scanned gels, using a standard curve for the protein
in question generated on the same gel. Prior to the assay, all formins
were diluted in MTB and centrifuged in a TLA100 at 60,000 rpm for
15 min at 25°C (supernatant used). When actin was used in these
assays, it was diluted to 5 μM in the presence of 10 μM latrunculin B
(LatB; Calbiochem) in MTB, incubated at 25°C for 1 h, and centrifuged in a similar manner as previously (supernatant used). When
profilin was used, it was added to the LatB–actin mix at 15 μM prior
to the incubation/centrifugation steps. Low-speed pelleting assays
were conducted in a similar manner, except that they were centriVolume 22 December 1, 2011

fuged at 4000 × g for 10 min at 25°C and the pellets were not
washed.
We note that neither affinity nor stoichiometry is significantly
affected by changing buffer components from our actin polymerization buffer to a microtubule stabilization buffer (Supplemental
Figure S6). We also note that the formin molar concentrations indicated in the figures use the monomer mass of each formin.
However, since the FH2 domain has been shown to dimerize for
all of these formins (Li and Higgs, 2005; Chhabra and Higgs,
2006), we use the dimer as the formin unit in our stoichiometry
calculations.

Microscopy assays
Fluorescent tubulin (Alexa 488–labeled tubulin and Alexa 568–labeled tubulin) was prepared according to Hyman et al. (1991).
Fluorescent tubulin (mixture of 5 μM Alexa 598–labeled tubulin
and 10 μM unlabeled tubulin) was incubated at 37°C in the absence or presence of INF2 constructs and sedimented on coverslips according to Gaillard et al. (2008). For observations of INF2
constructs binding on Taxol-stabilized microtubules (MTs), Alexa
598–labeled MTs (0.2 μM) were incubated for 5 min with either
GFP-INF2 FH1FH2C or INF2FH1FH2 (0.5 μM). Samples were observed using a fluorescence microscope (Axioplan 2 microscope
[Zeiss, Thornwood, NY], 63× magnification, numerical aperture
1.3 objective, Hamamatsu [Hamamatsu, Japan] charge-coupled
device Orca-1 camera, and MediaView image processing [Universal Imaging Corporation, West Chester, PA]). For negative-stain
electron microscope observations, MTs (4 μM) were incubated at
20°C for 20 min with INF2 constructs (2 μM). Samples were stained
with 2% (wt/vol) uranyl acetate and observed on a CM12 microscope (FEI, Eindhoven, Netherlands) operating at 120 kV.
MT dynamic behavior within INF2-FH1FH2C–induced bundles
was observed using TIRF microscopy. For the assays, stable MT
seeds were obtained according to Fache et al. (2010). Seed bundles
were obtained by incubating 1 μM MT seeds with 1 μM INF2FH1FH2C for 10 min at room temperature. To keep MT seeds within
the excitation field, we used NeutrAvidin Biotin-Binding Protein
(Pierce, Thermo Fisher Scientific, Rockford, IL) specific to biotin to
adhere MT seeds to the cover glass surface according to Fache
et al. (2010). Seeds and MT seed bundles were then elongated by
the addition of 22 μM tubulin (17 μM unlabeled tubulin, 5 μM of
Alexa-labeled tubulin), in the absence or the presence of 1 μM
INF2FH1FH2C, 1 mM GTP, an oxygen scavenger cocktail (2 mg/ml
glucose, 80 μg/ml catalase, 0.67 mg/ml glucose oxidase), and 1.5%
bovine serum albumin. Experiments were conducted in a final volume of 5 μl between glass covered with poly(l-lysine)–poly(ethylene
glycol) in order to limit interactions between MTs and the coverglass. MT dynamics was visualized at 32°C using an objective-based
total internal fluorescence microscope (Nikon TE2000-E). Excitation
was achieved using 491- and a 561-nm lasers to visualize GFP and
Alexa 568, respectively. Time-lapse microscopy (one frame every 2
or 5 s) was performed for 30 min using MetaMorph software, version
6.3r7 (Molecular Devices, Sunnyvale, CA), and frames were analyzed
using MetaMorph; “equalize light,” “basic filter,” and “flatten background” were the filters used to improve the signal/noise ratio.
MT bundle elongation and dynamics were analyzed using kymographs generated by MetaMorph and analyzed with ImageJ
(Bethesda, MD).

Actin polymerization and depolymerization assays
All assays were performed on a mixture of 90% unlabeled/10%
pyrene-labeled actin, using an Infinity M-1000 fluorescence plate
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reader (Tecan, Männedorf, Switzerland) or a PC1 spectrofluorimeter
(ISS, Champaign, IL). For polymerization assays, 3.33 μM actin
monomers in G buffer were converted to the Mg2+ salt by addition
of 0.1 volume of 10 mM EGTA/1 mM MgCl2 for 2 min at 23°C before starting the assay. Formins and microtubules were premixed at
23°C in buffer containing 75 mM KCl, 1.7 mM MgCl2, 1.7 mM EGTA,
15 mM imidazole-HCl, pH 7.0, 16 mM K-PIPES, pH 6.9, 0.1 mM
GTP, 0.5 mM thesit, 0.75 mM DTT, and 9 μM paclitaxel. Assays were
started by mixing 1 volume of actin with 2 volumes of formin–microtubule mix and monitored for pyrene fluorescence at 365-nm excitation and 407-nm emission at 27°C.
For depolymerization assays, 1.1 μM actin was polymerized at
least 15 h at 23°C in K50MEID + 0.5 mM thesit, then mixed with
0.1 volume of formin–microtubule mix in K50MEID + 0.5 mM thesit,
40 mM K-PIPES, pH 6.9, 0.5 mM MgCl2, 0.5 mM EGTA, 0.25 mM
GTP, and 10 μM paclitaxel. Decrease in pyrene fluorescence was
monitored as previously noted. In the depolymerization assays, ATP
concentration was <4 μM (contribution from the actin stocks).
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